A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335

Summary

The purpose of this study is to evaluate the pharmacokinetics (PK) of a single oral dose of AL-335 in participants with various degrees of impaired renal function (mild, moderate, and severe) compared to participants with normal renal function.

Timeline

Start

2016-09-13

Primary completion

2017-08-08

Completion

2017-08-16

Drugs

Indications